These findings are consistent with previous studies indicating that macrophage-derived CXCL10 can recruit stem-like TCF7+ CD8+ T cells, which predict effective tumor immunity and immune checkpoint blockade efficacy44,65. This evidence concerns the gene CD8A and neoplasm.